Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2 Bio) Gene Therapy (GT) Products
Sponsor: A2 Biotherapeutics Inc.
Summary
This protocol is to ensure consistent long-term follow-up for delayed safety events in participants who received A2 Bio gene therapy (GT) products.
Official title: A Long-Term Follow-Up Study of Participants Treated With A2 Biotherapeutics (A2Bio) Gene Therapy (GT) Products
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
400
Start Date
2025-08-31
Completion Date
2040-03-31
Last Updated
2025-07-15
Healthy Volunteers
No
Conditions
Interventions
No additional intervention administered in this long term follow-up study
Safety follow-up for A2 Bio GT products administered in a previous interventional study
Locations (2)
Mayo Clinic
Rochester, Minnesota, United States
NYU Langone Medical Center
New York, New York, United States